Cargando…
Poor reproducibility of PIRADS score in two multiparametric MRIs before biopsy in men with elevated PSA
PURPOSE: Since January 2015, all men referred to urologists in Norway due to elevated PSA or other suspicion of prostate cancer underwent multiparametric MRI (mpMRI) before prostate biopsy. At our hospital, patients and the initial MRI were assessed by an urologist and if deemed necessary, patients...
Autores principales: | Müller, Stig, Lilleaasen, Gunder, Sand, Tor Erik, Løfsgaard, Lars, Estop-Garanto, Manuela, Helgø, Dan, Sund, Peter, Mygland, Vegard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916982/ https://www.ncbi.nlm.nih.gov/pubmed/29508048 http://dx.doi.org/10.1007/s00345-018-2252-4 |
Ejemplares similares
-
The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions
por: Zattoni, Fabio, et al.
Publicado: (2023) -
Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
por: Malewski, Wojciech, et al.
Publicado: (2023) -
Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system
por: Alqahtani, Saeed, et al.
Publicado: (2020) -
Evaluation of PCA3 and multiparametric MRI’s: collective benefits before deciding initial prostate biopsy for patients with PSA level between 3-10ng/mL
por: Okcelik, Sezgin, et al.
Publicado: (2016) -
Multiparametric MRI in the PSA Screening Era
por: George, Arvin K., et al.
Publicado: (2014)